PT - JOURNAL ARTICLE AU - Kshitij Chatterjee AU - Chao-Ping Wu AU - Abhishek Bhardwaj AU - Matthew Siuba TI - Steroids in COVID-19: An overview AID - 10.3949/ccjm.87a.ccc059 DP - 2020 Aug 20 TA - Cleveland Clinic Journal of Medicine 4099 - http://www.ccjm.org/content/early/2020/08/18/ccjm.87a.ccc059.short 4100 - http://www.ccjm.org/content/early/2020/08/18/ccjm.87a.ccc059.full AB - Most antiviral or immunomodulatory therapies investigated for use in patients with COVID-19 have failed to show any mortality benefit. Similar to the previous pandemics caused by respiratory viruses, the role and benefit of corticosteroids has been under debate in COVID-19–related pulmonary disease. In this consult, we discuss the evidence regarding the efficacy of corticosteroid use in hospitalized patients with COVID-19, including data from the first randomized controlled trial on this subject.